首页> 美国卫生研究院文献>Critical Care >Critical care medicine in the 21st century: from CPR to PCR
【2h】

Critical care medicine in the 21st century: from CPR to PCR

机译:21世纪的重症监护医学:从CPR到PCR

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As in other areas of medicine, the specialty of critical care medicine, which has made important contributions in the pathophysiology of critical illness, is facing challenges that must be recognized and addressed in the current century. In this review, we argue that the skill set required to adequately treat critically ill patients will also require knowledge of molecular biology for better diagnosis and treatment. The foundations of molecular biology and genetics are essential for the understanding of the mechanisms of disease. Incorporating molecular biology techniques in the research arsenal of the intensivist will provide the opportunity to dissect out and define the reversible and irreversible intracellular processes giving rise to the major causes of mortality in intensive care units. Two historical paradigms, the cardiopulmonary resuscitation and polymerase chain reaction, summarize how critical care medicine began, and how it could mature in the years to come.
机译:与其他医学领域一样,在重症疾病的病理生理学中做出了重要贡献的重症监护医学专业正面临本世纪必须认识和应对的挑战。在这篇综述中,我们认为充分治疗重症患者所需的技能还需要分子生物学知识,以便更好地进行诊断和治疗。分子生物学和遗传学的基础对于理解疾病的机制至关重要。在强化医生的研究库中纳入分子生物学技术将提供剖析和定义可逆和不可逆细胞内过程的机会,从而引起重症监护病房的主要死亡原因。心肺复苏和聚合酶链反应是两个历史范式,总结了重症监护药物的开始方式以及在未来几年中如何成熟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号